510(k) K955355
K955355 is an FDA 510(k) premarket notification submitted by Bio-Rad for the device "VARIANT ALPHA-THALASSEMIA SHORT PROGRAM". The FDA issued a decision of Substantially Equivalent on Apr 26, 1996. The device falls under product code GKA (Abnormal Hemoglobin Quantitation), a Class II device regulated under 21 CFR 864.7415. Bio-Rad has 318 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 26, 1996
- Date Received
- Nov 21, 1995
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Abnormal Hemoglobin Quantitation
- Device Class
- Class II
- Regulation Number
- 864.7415
- Review Panel
- HE
- Submission Type
- 510(k)
Need the full FDA record for Bio-Rad? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.